SCHEMBL2309802

SCHEMBL2309802

O=C1C(=O)N(C(c2ccccc2)c2ccccc2)c2cccc(I)c21

nearest known ligand 0.35

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MGLL Q99685 1/20 0.35
MAPT P10636 2/20 0.35
NPSR1 Q6W5P4 2/20 0.35
KDM4E B2RXH2 1/20 0.35
LMNA P02545 1/20 0.35
MEN1 O00255 1/20 0.31
KMT2A Q03164 1/20 0.31
ALDH1A1 P00352 2/20 0.30
EGFR P00533 1/20 0.30
RAF1 P04049 1/20 0.30
ALOX12 P18054 1/20 0.30
MAPK1 P28482 1/20 0.30
MAP2K1 Q02750 1/20 0.30
L3MBTL1 Q9Y468 1/20 0.30
CES2 O00748 1/20 0.30
BCHE P06276 1/20 0.30
GAA P10253 1/20 0.30
CES1 P23141 1/20 0.30
CYP19A1 P11511 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3326055 0.81 GNRHR (0.35) MGLLMAPTNPSR1KDM4ELMNA
SCHEMBL2304261 0.81 IDO1 (0.42) MGLLMAPTNPSR1KDM4ELMNA
SCHEMBL281336 0.75 CES1 (0.50) NPSR1ALDH1A1CES2BCHEGAA
SCHEMBL14830556 0.72 NPSR1 (0.56) MGLLMAPTNPSR1MEN1KMT2A
SCHEMBL15206754 0.69 TTR (0.50) MGLLMAPTLMNAMEN1KMT2A
SCHEMBL2579627 0.69 ALDH1A1 (0.42) MAPTNPSR1KDM4ELMNAMEN1
SCHEMBL2306608 0.68 CHRM1 (0.49) NPSR1ALDH1A1CES2BCHEGAA
Hexane SCHEMBL28139534 0.67 ALDH1A1 (0.56) NPSR1ALDH1A1CES2BCHEGAA
SCHEMBL9720982 0.67 KMT2A (0.60) MAPTNPSR1KDM4ELMNAMEN1
SCHEMBL2304466 0.65 ALDH1A1 (0.54) ALDH1A1MAPK1L3MBTL1CES1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2350090-A2 SPIRO-OXINDOLE COMPOUNDS AND THEIR USE AS THERAPEUTIC AGENTS Xenon Pharmaceuticals Inc. (CA) 2011-08-03 EP disclosed
WO-2010045251-A2 SPIRO-OXINDOLE COMPOUNDS AND THEIR USE AS THERAPEUTIC AGENTS XENON PHARMACEUTICALS, INC. (CA) 2010-04-22 WO disclosed